258 related articles for article (PubMed ID: 28804920)
1. Thiopurines prevented surgical recurrence in patients with Crohn's disease after intestinal resection: Strategy based on risk stratification.
Guo J; Chen BL; Chen ZH; Luo XP; Qiu Y; Zhang SH; Feng R; He Y; Zeng ZR; Song XM; Ben-Horin S; Mao R; Chen MH
J Gastroenterol Hepatol; 2018 Mar; 33(3):608-614. PubMed ID: 28804920
[TBL] [Abstract][Full Text] [Related]
2. Mercaptopurine versus placebo to prevent recurrence of Crohn's disease after surgical resection (TOPPIC): a multicentre, double-blind, randomised controlled trial.
Mowat C; Arnott I; Cahill A; Smith M; Ahmad T; Subramanian S; Travis S; Morris J; Hamlin J; Dhar A; Nwokolo C; Edwards C; Creed T; Bloom S; Yousif M; Thomas L; Campbell S; Lewis SJ; Sebastian S; Sen S; Lal S; Hawkey C; Murray C; Cummings F; Goh J; Lindsay JO; Arebi N; Potts L; McKinley AJ; Thomson JM; Todd JA; Collie M; Dunlop MG; Mowat A; Gaya DR; Winter J; Naismith GD; Ennis H; Keerie C; Lewis S; Prescott RJ; Kennedy NA; Satsangi J;
Lancet Gastroenterol Hepatol; 2016 Dec; 1(4):273-282. PubMed ID: 28404197
[TBL] [Abstract][Full Text] [Related]
3. Thiopurines are associated with a reduction in surgical re-resections in patients with Crohn's disease: a long-term follow-up study in a regional and academic cohort.
van Loo ES; Vosseberg NW; van der Heide F; Pierie JP; van der Linde K; Ploeg RJ; Dijkstra G; Nieuwenhuijs VB
Inflamm Bowel Dis; 2013 Dec; 19(13):2801-8. PubMed ID: 24189041
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of Mesalazine, Thiopurines and Tumour Necrosis Factor Antagonists in Preventing Post-Operative Crohn's Disease Recurrence in a Real-Life Setting.
Allocca M; Landi R; Bonovas S; Fiorino G; Papa A; Spinelli A; Furfaro F; Peyrin-Biroulet L; Armuzzi A; Danese S
Digestion; 2017; 96(3):166-172. PubMed ID: 28903094
[TBL] [Abstract][Full Text] [Related]
5. The impact of thiopurines on the risk of surgical recurrence in patients with Crohn's disease after first intestinal surgery.
Papay P; Reinisch W; Ho E; Gratzer C; Lissner D; Herkner H; Riss S; Dejaco C; Miehsler W; Vogelsang H; Novacek G
Am J Gastroenterol; 2010 May; 105(5):1158-64. PubMed ID: 20010925
[TBL] [Abstract][Full Text] [Related]
6. Prevention of postoperative recurrence with azathioprine or infliximab in patients with Crohn's disease: an open-label pilot study.
Armuzzi A; Felice C; Papa A; Marzo M; Pugliese D; Andrisani G; Federico F; De Vitis I; Rapaccini GL; Guidi L
J Crohns Colitis; 2013 Dec; 7(12):e623-9. PubMed ID: 23810678
[TBL] [Abstract][Full Text] [Related]
7. Immediate prophylactic vs endoscopic or symptomatic-driven azathioprine treatment to prevent surgical recurrence after intestinal resection for Crohn's disease.
Guo Z; Cai X; Liu R; Gong J; Li Y; Cao L; Wang Z; Zhu W
Colorectal Dis; 2018 Sep; 20(9):O267-O276. PubMed ID: 30051962
[TBL] [Abstract][Full Text] [Related]
8. Early use of thiopurines or methotrexate reduces major abdominal and perianal surgery in Crohn's disease.
Kariyawasam VC; Selinger CP; Katelaris PH; Jones DB; McDonald C; Barr G; Chapman G; Colliwshaw J; Lunney PC; Middleton K; Wang RR; Huang T; Andrews J; Leong RW
Inflamm Bowel Dis; 2014 Aug; 20(8):1382-90. PubMed ID: 24991785
[TBL] [Abstract][Full Text] [Related]
9. Strategies for the prevention of postoperative recurrence of Crohn's disease.
Yamamoto T; Watanabe T
Colorectal Dis; 2013 Dec; 15(12):1471-80. PubMed ID: 23809911
[TBL] [Abstract][Full Text] [Related]
10. Prevention of postoperative recurrence of Crohn's disease.
van Loo ES; Dijkstra G; Ploeg RJ; Nieuwenhuijs VB
J Crohns Colitis; 2012 Jul; 6(6):637-46. PubMed ID: 22398096
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic features of Crohn's disease associated with failure of medical treatment.
Moran GW; Dubeau MF; Kaplan GG; Yang H; Seow CH; Fedorak RN; Dieleman LA; Barkema HW; Ghosh S; Panaccione R;
Clin Gastroenterol Hepatol; 2014 Mar; 12(3):434-42.e1. PubMed ID: 23978351
[TBL] [Abstract][Full Text] [Related]
12. Azathioprine for prevention of postoperative recurrence in Crohn's disease: a retrospective study.
Cuillerier E; Lémann M; Bouhnik Y; Allez M; Rambaud JC; Modigliani R
Eur J Gastroenterol Hepatol; 2001 Nov; 13(11):1291-6. PubMed ID: 11692053
[TBL] [Abstract][Full Text] [Related]
13. Repeat intestinal resections increase the risk of recurrence of Crohn's disease.
Riss S; Schuster I; Papay P; Mittlböck M; Stift A
Dis Colon Rectum; 2013 Jul; 56(7):881-7. PubMed ID: 23739195
[TBL] [Abstract][Full Text] [Related]
14. [Azathioprine and 5-ASA in the prevention of postoperative recurrence of Crohn's disease].
Nos P; Hinojosa J; Aguilera V; Molés JR; Pastor M; Ponce J; Berenguer J
Gastroenterol Hepatol; 2000 Oct; 23(8):374-8. PubMed ID: 11227650
[TBL] [Abstract][Full Text] [Related]
15. Impact of azathioprine on the prevention of postoperative Crohn's disease recurrence: results of a prospective, observational, long-term follow-up study.
Domènech E; Mañosa M; Bernal I; Garcia-Planella E; Cabré E; Piñol M; Lorenzo-Zúñiga V; Boix J; Gassull MA
Inflamm Bowel Dis; 2008 Apr; 14(4):508-13. PubMed ID: 18183602
[TBL] [Abstract][Full Text] [Related]
16. Myenteric plexitis is a risk factor for endoscopic and clinical postoperative recurrence after ileocolonic resection in Crohn's disease.
Decousus S; Boucher AL; Joubert J; Pereira B; Dubois A; Goutorbe F; Déchelotte PJ; Bommelaer G; Buisson A
Dig Liver Dis; 2016 Jul; 48(7):753-8. PubMed ID: 27005857
[TBL] [Abstract][Full Text] [Related]
17. Risk Prediction and Comparative Efficacy of Anti-TNF vs Thiopurines, for Preventing Postoperative Recurrence in Crohn's Disease: A Pooled Analysis of 6 Trials.
Beelen EMJ; Nieboer D; Arkenbosch JHC; Regueiro MD; Satsangi J; Ardizzone S; López-Sanromán A; Savarino E; Armuzzi A; Janneke van der Woude C; de Vries AC
Clin Gastroenterol Hepatol; 2022 Dec; 20(12):2741-2752.e6. PubMed ID: 34687970
[TBL] [Abstract][Full Text] [Related]
18. Presence of Granulomas in Mesenteric Lymph Nodes Is Associated with Postoperative Recurrence in Crohn's Disease.
Li Y; Stocchi L; Liu X; Rui Y; Liu G; Remzi FH; Shen B
Inflamm Bowel Dis; 2015 Nov; 21(11):2613-8. PubMed ID: 26218143
[TBL] [Abstract][Full Text] [Related]
19. Ustekinumab is more effective than azathioprine to prevent endoscopic postoperative recurrence in Crohn's disease.
Buisson A; Nancey S; Manlay L; Rubin DT; Hebuterne X; Pariente B; Fumery M; Laharie D; Roblin X; Bommelaer G; Pereira B; Peyrin-Biroulet L; Vuitton L;
United European Gastroenterol J; 2021 Jun; 9(5):552-560. PubMed ID: 33951350
[TBL] [Abstract][Full Text] [Related]
20. Addition of metronidazole to azathioprine for the prevention of postoperative recurrence of Crohn's disease: a randomized, double-blind, placebo-controlled trial.
Mañosa M; Cabré E; Bernal I; Esteve M; Garcia-Planella E; Ricart E; Peñalva M; Cortes X; Boix J; Piñol M; Gassull MA; Domènech E
Inflamm Bowel Dis; 2013 Aug; 19(9):1889-95. PubMed ID: 23689809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
